Search

Mark J Hokenson

from Camarillo, CA
Age ~50
Get Report
Also known as:
Mark Jason Hokenson
Phone and address:
6153 Calle Arena, Camarillo, CA 93012
(805) 383-3141
Related to:
Paula ElsasserDeborah Butler, 90
Connected to:
Barbara A Hokenson, 55Brock K Hokenson, 45Earl P Hokenson, 83Eric Hokenson, 54Gustave J Hokenson, 78Hannah E Hokenson, 33Lori L Hokenson, 44Michelle K Hokenson, 59Sandra S Hokenson, 71Brandon L Hokenstad, 48

Mark Hokenson Phones & Addresses

  • 6153 Calle Arena, Camarillo, CA 93012 (805) 383-3141
  • West Covina, CA
  • 2365 Martinique Ln, Oxnard, CA 93035 (805) 815-3787
  • Monrovia, CA
  • 28337 Mayfair Dr, Valencia, CA 91354 (661) 297-5821
  • Ben Lomond, CA
  • Shelton, CT

Work

Company: Integrity bio, inc. May 2012 Address: Camarillo, CA Position: Associate director

Education

Degree: PhD School / High School: University of California, Santa Cruz 1997 to 2002 Specialities: Biochemistry

Skills

Protein Chemistry • HPLC

Industries

Biotechnology

Resumes

Resumes

Mark Hokenson Photo 1

Associate Director At Integrity Bio

View page
Position:
Associate Director at Integrity Bio, Inc.
Location:
Greater Los Angeles Area
Industry:
Biotechnology
Work:
Integrity Bio, Inc. - Camarillo, CA since May 2012
Associate Director
Integrity Bio, Inc. - Camarillo, CA Jul 2011 - May 2012
Senior Scientist
PerQFlo, LLC Apr 2011 - Jul 2011
Consultant - analytical / biophysical services
MannKind Corporation Jun 2005 - Apr 2011
Senior Scientist
University of California, Santa Cruz Jun 2002 - Jun 2005
Post-Doctoral Protein Chemist
Education:
University of California, Santa Cruz 1997 - 2002
PhD, Biochemistry California State Polytechnic University-Pomona 1991 - 1997
BS, Chemistry
Skills:
Protein Chemistry
HPLC

Publications

Us Patents

Method Of Drug Formulation Of Compositions Comprising Crystalline Microparticle Surfaces

View page
US Patent:
8420604, Apr 16, 2013
Filed:
Jun 14, 2010
Appl. No.:
12/815276
Inventors:
Mark Hokenson - Valencia CA, US
Keith A. Oberg - Valencia CA, US
Assignee:
Mannkind Corporation - Valencia CA
International Classification:
A61K 38/13
A61K 9/14
A61K 9/28
A61P 37/04
US Classification:
514 205, 424490
Abstract:
Methods are provided for promoting the adsorption of an active agent to microparticles by modifying the structural properties of the active agent in order to facilitate favorable association to the microparticle.

Method Of Drug Formulation Based On Increasing The Affinity Of Active Agents For Crystalline Microparticle Surfaces

View page
US Patent:
20070059374, Mar 15, 2007
Filed:
Sep 14, 2006
Appl. No.:
11/532065
Inventors:
Mark Hokenson - Valencia CA, US
Keith Oberg - Valencia CA, US
International Classification:
A61K 9/28
A61K 38/28
A61K 38/13
A61K 39/395
A61K 9/14
US Classification:
424489000, 427002140, 514003000, 514011000, 514012000, 424133100
Abstract:
Methods are provided for promoting the adsorption of an active agent to microparticles by modifying the structural properties of the active agent in order to facilitate favorable association to the microparticle.

Glucagon-Like Peptide 1 (Glp-1) Pharmaceutical Formulations

View page
US Patent:
20080260838, Oct 23, 2008
Filed:
Apr 16, 2007
Appl. No.:
11/735957
Inventors:
Mark J. Hokenson - Valencia CA, US
David Brandt - Valencia CA, US
Mark King - Pasadena CA, US
Stephanie Greene - Ventura CA, US
Mary Faris - Los Angeles CA, US
Keith Oberg - Valencia CA, US
Wayman Wendell Cheatham - Columbia MD, US
Cohava Gelber - Manassas VA, US
Assignee:
MANNKIND CORPORATION - Valencia CA
International Classification:
A61K 9/14
A61K 38/16
A61P 3/10
A61P 3/04
A61P 35/00
US Classification:
424489, 514 12
Abstract:
A composition is disclosed comprising glucagon-like peptide 1 (GLP-1) particles in combination with diketopiperazine (DKP) that is stable both in vitro and in vivo. The composition has utility as a pharmaceutical formulation for treating diseases such as diabetes, cancers, and obesity but is not limited to such diseases or conditions. In particularly, the composition has utility as a pharmaceutical formulation for pulmonary delivery.

Method Of Drug Formulation Based On Increasing The Affinity Of Active Agents For Crystalline Microparticle Surfaces

View page
US Patent:
20110003004, Jan 6, 2011
Filed:
Sep 16, 2010
Appl. No.:
12/883369
Inventors:
Mark Hokenson - Valencia CA, US
Keith A. Oberg - Valencia CA, US
Assignee:
Mannkind Corporation - Valencia CA
International Classification:
A61K 9/14
A61K 38/02
A61K 38/28
A61K 38/22
A61K 38/27
A61K 38/29
US Classification:
424491, 514 11, 514 59, 514 97, 514 113, 514 118
Abstract:
Methods are provided for promoting the adsorption of an active agent to microparticles by modifying the structural properties of the active agent in order to facilitate favorable association to the microparticle.
Control profile
Mark J Hokenson from Camarillo, CA, age ~50 Get Report